Epidemiology of HIV-1 transmitted drug resistance
Tuesday, April 7, 2015 - 16:00
in Health & Medicine
Only a limited number of surveillance drug-resistance mutations are responsible for most instances of non-nucleoside reverse transcriptase inhibitor- and nucleoside reverse transcriptase inhibitor-associated resistance, and most strains of HIV-1 transmitted drug resistance in sub-Saharan Africa and south/southeast Asia arose independently, according to a new study.